approval
saveXARELTO (RIVAROXABAN) — FDA approval
March 24, 2026updated 5mo ago
community read0 votes
Sponsor: JANSSEN PHARMS. Form: FOR SUSPENSION. Route: ORAL
view source ↗Data sources
last refreshed 5mo ago
Found something off?
same company · ±60 days · 6
- approvalXARELTO (RIVAROXABAN) — FDA approvalMar 24, 2026
- approvalCONCERTA (METHYLPHENIDATE HYDROCHLORIDE) — FDA approvalApr 10, 2026
- approvalTOPAMAX SPRINKLE (TOPIRAMATE) — FDA approvalMar 6, 2026
- approvalTOPAMAX (TOPIRAMATE) — FDA approvalMar 6, 2026
- approvalSPRAVATO (ESKETAMINE HYDROCHLORIDE) — FDA approvalApr 13, 2026
- drug shortageMethylphenidate Hydrochloride Tablet, Extended Release shortage — Janssen PharmaceuticalsApr 17, 2026
comments(0)
5-min edit window · permanent after that